Neurocrine Bio. (NBIX) PT Raised to $120 at SVB Leerink

August 4, 2020 5:04 AM

SVB Leerink analyst Marc Goodman raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $120.00 (from $105.00) while maintaining a Market Perform rating.

No results found